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Abstract   20 
Background: Previously developed in vitro cultures of the human retina have been solo 21 
or dual cell cultures. We developed a triple-cell culture in vitro model utilizing a 22 
membrane system to produce a better representation of a functional and morphological 23 
human retina.  24 
Methods: Retinal microvascular endothelial cells (HRMVEC/ACBRI181, Cell systems), 25 
retinal pigment epithelium cells (RPE/ARPE-19, ATCC) and Müller glial cells (MIO-M1, 26 
UCL) were grown in a triple-culture. Our optimized triple-culture media contained a mix 27 
of specific endothelial medium and high glucose Dulbecco's Modified Eagle's medium 28 
(DMEM), where all three layers were viable for up to 5 days. Co-culture effect on 29 
morphological changes (cell staining) and gene expression of functional genes (pigment 30 
epithelial derived factor (PEDF) and vascular endothelial growth factor (VEGF)) were 31 
measured from RNA via real time PCR. Expression of tight junction protein 1 (TJP1) was 32 
measured in RNA isolated from ARPE-19s, to assess barrier stability.  33 
Results: The triple-culture promotes certain cell functionality through up-regulation of 34 
TJP1, increasing PEDF and decreasing VEGF expression highlighting its importance for 35 
the assessment of disease mechanisms distinct from a solo culture which would not 36 
allow the true effect of the native microenvironment to be elucidated. 37 
Conclusion: This model’s novelty and reliability allows for the assessment of singular 38 
cellular function within the retinal microenvironment and overall assessment of retinal 39 
health, whilst eliminating the requirement of animal-based models. 40 




1. Introduction 43 
The human eye is a complex organ that is comprised of three main areas; the cornea, 44 
lens, and the retina. The retina is a highly specialised organ of photoreception, involved 45 
in translating light energy into action potentials which are relayed to the brain, where 46 
the information is processed into vision. The integrity of the retina is dependent upon 47 
its immediate microenvironment, which is reliant on cell-cell interactions of the 48 
different human retinal cellular components. Disruption of which results in a variety of 49 
retinal diseases including diabetic retinopathy (DR)1. DR is associated with the 50 
breakdown of both the inner blood-retinal-barrier (BRB)2, 3 and more recently linked to 51 
the outer BRB4. The inner BRB is composed of tight junctions between retinal capillary 52 
endothelial cells and the outer of tight junctions between the retinal pigment epithelial 53 
cells (RPE). The inter-relationship between vascular and endothelial cells that form the 54 
BRB is vital maintaining a specialized environment of the neural retina.  55 
Current findings show that BRB breakdown is multifactorial, including;  impaired 56 
endothelial cells, pericyte demise, thickening of capillary basement membrane and the 57 
alteration of tight junctions between RPE and endothelial cells5. Additionally RPE, 58 
endothelial and other cell types within the retina can be responsible for the release of 59 
neurotrophic factors that can alter the integrity of the BRB, such as vascular endothelial 60 
growth factor (VEGF) and pigment endothelial derived factor (PEDF)6-8. These factors 61 
can also be released from Müller cells8-10, which are a subset of the retinal macroglia 62 
that are strongly linked to RPEs, establishing structural connections with the subretinal 63 
space and choroidal vasculature8, 11. It is evident that research into DR requires a 64 
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complex system that can encompass the interaction of all cells present within both the 65 
inner and outer BRB.  66 
Currently research into retinal disease utilizes two main methodologies; in vitro 67 
analysis of solo or dual cell cultures, and animal models. The current literature and 68 
project designs relating to RPE cultures are often limited to them encompassing a dual-69 
culture system with endothelial cells. The culture formations published comprise of cells 70 
either in direct contact12, sandwiched with extracellular matrix proteins13, 14, or cells 71 
cultured on either side of a membrane15-17. Alternatively, there are published models 72 
that encompass a dual system where these cells do not come into contact18. There are 73 
very few multi-culture systems within literature, with those published comprising of 74 
mixed species cell sources19. We aim to expand on current in vitro models to develop a 75 
triple-culture which utilizes both human cell lines and primary cells, to demonstrate a 76 
better representation of a functional and morphological human retina.  77 
 78 
2. Methods 79 
Cell line and isolated primary cell culture 80 
Retinal pigment epithelial cells 81 
RPE were authenticated and sourced as a commercially available cell line; ARPE-19 82 
(ATCC® CRL-2302, USA). Upon receipt were grown in Dulbecco’s Modified Eagle’s 83 
medium (DMEM) containing glutamine supplemented with 10% fetal bovine serum 84 
(FBS) and 1% penicillin-streptomycin (Invitrogen-Gibco, Rockville, MD). Cells were 85 
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incubated at 37°C at 5% CO2, with media changed every 2-3 days and sub-cultured (1:3 86 
split) at 80% confluency with 0.05% trypsin-EDTA (Invitrogen-Gibco, Rockville, MD).  87 
Müller glial cells 88 
Human Moorfield Institute of Ophthalmology-Müller 1 (MIO-M1) cell line were isolated, 89 
authenticated and purchased from Professor Limb (Institute of Ophthalmology and 90 
Moorfields Eye Hospital,  UK)20.Upon arrival, cells were cultured in the same media as 91 
ARPE-19, incubated at 37°C at 5% CO2 and media changed every 2-3 days.  92 
Retinal microvascular endothelial cells 93 
Primary human retinal microvascular endothelial cells (HRMVEC) are commercially 94 
available, sourced from Applied Cell Biology Research Institute (ACBRI 181, Cell Systems, 95 
Kirkland, USA).  All experimental procedures completed using primary cells were in 96 
compliance with the Human Tissue Act. Cells were grown in Cell Systems Culture (CS-C) 97 
medium, incubated at 37°C at 5% CO2, with media changed every 2-3 days. Cells were 98 
passaged when confluent using Cell Systems Passage Reagent (all reagents sourced from 99 
Cell Systems, Kirkland, USA) and used in experiments at passage 8.  100 
 101 
Co-culture formation 102 
To assess cell viability in a microenvironment, cells were grown in solo, dual (MIO-M1 & 103 
ARPE-19, ARPE-19 & HRMVEC and MIO-M1 & HRMVEC) and triple formations (ARPE-19, 104 
MIO-M1 & HRMVEC), using the following protocol.  105 
 106 
System set-up 107 
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During solo-, dual- and triple-culture formations all cell types were grown in the same 108 
location as seen within triple-culture schematic (Figure 1). Multi-culture system utilizes 109 
a 0.4 µm pore size polyester (PET) Transwell® membrane with a 10 µm membrane 110 
thickness (Corning, Thermo Scientific, UK). Cells were plated according to Figure 1, using 111 
an in-house optimized multi-culture media (MC media) consisting of 2:1 DMEM with 112 
glutamine: CS-C medium.   113 
 114 
Figure 1. Triple-culture schematic for ARPE-19 (R), MIO-M1 (M) and HRMVEC (E). Annotated medium is 115 
the culturing medium present in both well insert and culture dish well as described in methodology, multi- 116 
culture. (MC).  117 
 118 
Cell seeding and maturation 119 
ARPE-19 was grown on the base of a 6-well culture dish, as shown (Figure 1). Cells were 120 
prepared for all experiments at passage 6, split ratio 1:3, requiring maturation and tight-121 
junction formation for 28 days with growth media changed every 2-3 days (Supp. Figure 122 
1A). At day 28, MIO-M1 cells were seeded at 100,000 cells per cm2 in 150 µL (passage 123 
34) onto the basal side of a Transwell® membrane by inverting the membrane structure 124 
and incubated for 3 hours at 37°C at 5% CO2. Once adhered, excess medium was 125 
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removed, the membrane reversed and placed in the 6-well culture plate containing the 126 
ARPE-19 cells. At day 32, HRMVEC were seeded at 100,000 cells per cm2 to the apical 127 
surface of the membrane insert washed with attachment factor, and grown in 1.5 mL 128 
MC medium, cells reached optimal confluency (70%) for experimentation after 48 hours 129 
(day 34).  MC media of well and insert was replenished every 2-3 days, cell viability valid 130 
for up to 5 days of construction of complete model (i.e. day 37) due to cellular 131 
characteristics and phenotypes of specific cell lines being lost after prolonged culture (> 132 
14 days)20.   133 
For permeability assay, an alternative layout was assembled to assess barrier 134 
properties as original triple-culture layout does not allow for this. Cells were cultured as 135 
described previously, but with cell seeding and maturation occurring in alternative 136 
positions i.e. ARPE-19 grown on apical surface of the membrane, MIO-M1 on basal 137 
surface and HRMVEC on bottom of the culture well (Figure 2).  138 
 139 
 140 
Figure 2. A- Alternative formation of multi-culture to assess Transwell® permeability in a multi-culture. R-141 




Morphological changes 144 
Immunocytochemical analysis was conducted to ensure the presence of correct cell 145 
types within culture (See Supp. Work 1 and Supp. Figure 1). Basic cell morphologies and 146 
relative diameter were determined using Hematoxylin (Sigma) staining and digital 147 
imaging via light microscopy. Cell quantification, density and diameter were assessed 148 
using ImageJ software (NIH, Version 2). Limitations of a basic cell imaging only allows 149 
data to be used as a relative check for cell morphology instead of a quantification of 150 
absolute size. Each experimental well produced images in 5 fields, each field was pre-151 
defined and set prior to cell seeding to remove experimental bias. A total of 20 cells per 152 
type at x50 magnification were analysed to determine cell diameter and morphologies 153 
(n=100 cells for data analysis, per biological repeat) (representation of images provided 154 
in Supp. Figure 2). Each cell type was analysed within 3 biological repeats.  155 
 156 
Gene expression analysis 157 
All expression data was collected from each culture layout from three biological repeats 158 
and three experimental repeats per plate (n=9 per culture layout). Individual cells types 159 
were harvested at day 32 of culture, homogenized in QIAzol lysis reagent and total RNA 160 
isolated using a RNeasy Mini Kit (Qiagen, UK). 1000ng/µl of total RNA was converted to 161 
cDNA using a reverse transcription kit (Invitrogen, Thermo Fisher, UK). 1:10 dilutions of 162 
cDNA transcripts were run on a CFX connect (BioRad, UK) using SYBR Green I (BioRad, 163 
UK) for each primer set (VEGF: Forward-ACT TCT GGG CTG TTC TC, Reverse-TCC TCT TCC 164 
TTC TCT TCT TCC; PEDF: Forward-TGC AGG CCC AGA TGA AAG GG, Reverse-TGA ACT CAG 165 
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AGG TGA GGC TC. TJP1: sourced and optimized from BioRad, UK) at optimal cycling 166 
conditions of; 95°C for 3min, followed by 35 cycles of 95°C for 30s, 59.5°C for 30s and 167 
72°C for 30s, followed by melt peak conditions. The average Ct value was 168 
taken from triplicate assays and normalised against the invariant expression of β-169 
actin housekeeper gene. Result were analysed using the 2-ΔΔCt method to produce 170 
relative fold change values in comparison between groups, standard error of the mean 171 
(SEM) was calculated from the average Ct value for each sample produced within the 172 
experiment cohort. Fold change range of -1.5 to 1.5 is indicative of no overall change in 173 
gene expression levels.   174 
 175 
Permeability assay 176 
Permeability assays were completed to assess barrier properties in a mixed cell 177 
environment, based on a horseradish peroxidase (HRP) (Sigma™) diffusion ELISA (n=9, 178 
per culture layout). For permeability assays, DMEM without FCS was used at all stages. 179 
An alternative layout of both dual- and triple-culture was used to assess Transwell® 180 
permeability due to the functional properties of each cell type. To assess the implication 181 
of culture formation on both ARPE-19 and HRMVEC, they were grown on the apical and 182 
basal side of the membrane, respectively. Medium within the well and insert 183 
compartments were replaced for assay media and the insert compartment dosed with 184 
HRP [1250 mU], incubated for 20 minutes and medium from the lower well 185 
compartment collected for analysis.  Culture media was transferred to a 96-well clear 186 
microplate plate for colorimetric analysis via 3,3',5,5'-Tetramethylbenzidine (TMB) and 187 
stop solution (Invitron, UK) and absorbance recorded at a wavelength of 450 nm and 188 
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corrected at 620 nm.  Membrane permeability was analysed in comparison to a control 189 
membrane with no cellular growth. Relative permeability was produced as a 190 
percentage;  191 
𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅 𝑃𝑃𝑅𝑅𝑃𝑃𝑃𝑃𝑅𝑅𝑅𝑅𝑃𝑃𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑃𝑃 (%) =
𝐶𝐶𝐶𝐶𝑅𝑅𝑅𝑅𝐶𝐶𝑃𝑃𝑅𝑅 𝐸𝐸𝐸𝐸𝐸𝐸𝑅𝑅𝑃𝑃𝑅𝑅𝑃𝑃𝑅𝑅𝐸𝐸𝑅𝑅 𝑉𝑉𝑅𝑅𝑅𝑅𝐶𝐶𝑅𝑅
𝐶𝐶𝐶𝐶𝐸𝐸𝑅𝑅𝑃𝑃𝐶𝐶𝑅𝑅 𝑉𝑉𝑅𝑅𝑅𝑅𝐶𝐶𝑅𝑅
 𝐸𝐸 100 192 
 193 
Statistical analysis 194 
Raw data was analysed using SPSS™ Version 23. Continuous data is summarized by mean 195 
and standard deviation (SD) when normally distributed, and by median and interquartile 196 
range (IQR) if not normally distributed. Normality of the data was verified by the 197 
Kolmogorov-Smirnov test and visualised on q-q plots. A Student t-test was used to 198 
compare the mean of two groups and analysis of variance (ANOVA) to compare the 199 
mean of more than two groups for normally distributed data. Alternatively, not normally 200 
distributed data was analysed using Mann Whitney U and Kruskal Wallis tests. For gene 201 
expression data, statistical analysis was run on threshold cycle (Ct) data normalised 202 
against β-actin housekeeper, assessed using Student t-test. P-values less than 0.05 were 203 
deemed statistically significant. 204 
 205 
3. Results 206 
Cell morphology 207 
Across all three cell types, no significant alterations in cell morphologies were noted in 208 
any culture formation (Table 1). Analysis of HRMVEC morphologies using cellular 209 
staining and microscopy was unable to produce sufficient images within the triple-210 
culture to assess cell diameter. RNA spectroscopy did confirm cell growth on the apical 211 
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surface and we believe a lack of imaging reflect limitations within methodology.  Gene 212 
expression of TJP1 was measured in RNA isolated from ARPE-19 to assess barrier stability 213 
in a multi-culture system. Data indicates a significant increase in fold change (FC) for 214 
TJP1 when RPE are grown in combination with either MIO-M1 (+11.4 FC, p<0.001), 215 
HRMVEC (+12.9 FC, p<0.001) or both in a triple-culture (+7.8 FC, p<0.001) (Figure 3). 216 
Barrier permeability was not assessed within the primary formation of the dual- and 217 
triple-culture as described in methodology. 218 
 219 
Table 1. Mean and standard deviation of cell diameter (µM) for the three cell types grown in all culture 220 





















Solo 17.5 (6.1) 62.7 (13.3) 98.9 (24.4) 
Dual  61.9 (10.6) 97.8 (28.0) 
Dual 18.1 (4.3)  96.0 (22.9) 
Dual 17.9 (4.5) 63.8 (13.9)  
Triple 18.2 (5.3) 62.5 (14.3) - 




Figure 3. Relative fold change values for TJP1 gene expression data in multi-culture formations in 234 
comparison to solo-culture. Fold change between -1.5 and 1.5 is classed as no relative gene expression 235 
change (grey shaded region). Statistical significance represented by asterisks (**p<0.01), determined 236 
using an independent t-test. R-ARPE-19, M-MIO-M1 and E-HRMVEC.  237 
 238 
Implications of multi-culture on gene expression levels 239 
PEDF expression (Figure 4A) demonstrated an increase in FC in both ARPE-19 (+5.2 FC, 240 
p<0.01) and MIO-M1 (+7.5 FC, p<0.05) in triple compared to solo-culture. Triple 241 
compared to solo-culture demonstrated no significant FC in VEGF expression in either 242 
MIO-M1 (+1.0 FC, p=0.49) or ARPE-19 (+0.6 FC, p=0.34) (Figure 4B). However, expression 243 
was significantly decreased within HRMVEC (-3.2 FC, p<0.05). Sub-analysis of dual-244 
cultures implicates MIO-M1 for the observed change in VEGF expression (dual-culture 245 
of; MIO-M1+HRMVEC, -6.0 FC, p<0.05 and dual-culture; ARPE-19+HRMVEC, +1.80 FC, 246 
p=0.11). 247 




Figure 4A-B. Relative fold change values for gene expression data in multi-culture formations in 250 
comparison to solo-culture. Fold change between -1.5 and 1.5 is classed as no relative gene expression 251 
change (grey shaded region). (A) PEDF-fold change & (B) VEGF-fold change. Statistical significance 252 
represented by asterisks (*p<0.05, **p<0.01), determined using an independent t-test of the difference 253 
of ΔCt in multi-culture formation of cells versus solo-cultured cells. 254 
 255 
Assessment of multi-culture on membrane properties 256 
HRP diffusion across the Transwell® membrane altered significantly dependent on the 257 
cells grown on the surface. ARPE-19 monolayer formation resulted in the diminishing of 258 
HRP passing through the membrane, this barrier was significantly strengthened in the 259 
presence of MIO-M1 grown on the basal side of the membrane in both a dual- and triple-260 
culture (ARPE-19 vs ARPE-19/MIO-M1; 34.1 (3.9)% v 25.7 (1.2)%: p<0.01; ARPE-19 vs 261 
ARPE-19/MIO-M1/HRMVEC; 34.1 (3.9)% vs 26.5 (0.5)%: p<0.01) (Figure 5). Diffusion of 262 
molecules through the Transwell® membrane is significantly reduced by cell growth on 263 
the surface, data demonstrated minimal relative permeability is 25.7% (±1.2) indicating 264 




Figure 5. HRP diffusion assay, relative permeability (%) for all cell formations that require growth on the 267 
Transwell® membrane, error bars indicate standard deviation. Statistical significance represented by 268 
asterisks (**p<0.01), determined using an independent t-test. R-ARPE-19, M-MIO-M1 and E-HRMVEC.  269 
 270 
4. Discussion 271 
This study presents the evidence for a novel human in vitro model of the retina. This 272 
model is reproducible and provides flexibility in formation and structure to maximise 273 
the yield of experimental research that can be conducted, including mechanistic 274 
research into retinal disease, retina biology and pharmacology intervention. The culture 275 
model allows for the arrangement of cellular components that mimic the retinal 276 
microvasculature, neuronal retina and RPE in vivo, allowing us to explore the tissues 277 
cellular microenvironment. The triple-culture model represents the close contacting 278 
relationship between the Müller glial cells (MIO-M1) and the blood vessels (HRMVEC) 279 
within the retina and the distal location of the non-contacting RPE (ARPE-19) retinal 280 
layer (Figure 6)21. These cell types in particular play a pivotal role in the function of the 281 
BRB and investigation of their cross-communication could lead to great enhancements 282 
for understanding retinal disease that results in, or is the result of, BRB malfunction.  283 
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Our findings highlight the importance of cell to cell interaction in retinal biology, 284 
with multi-culture systems resulting in changes in both structural and genetic alterations 285 
when compared to solo-cultures. On the other hand, the assessment of cell morphology 286 
resulted in no significant changes when the cells were grown in solo or in formations 287 
with each other. However, the methodology used to assess morphology is a basic 288 
technique and is limited in quantification and should only be utilised as an indication of 289 
cell type presence. We propose that within future expansion of this model, investigation 290 
into an optimized confocal analysis of cell markers across the membrane will confirm 291 
and quantify our original findings.  292 
 293 
Figure 6. Schematic drawing of the cellular components of the retina taken from Vecino et al, 201621. The 294 
different cell types are situated in a standard large mammalian retina, depicting the interactions between 295 
the Müller cells in blue (M) and blood vessels (BV) (represented in triple-culture model with HRMVEC). 296 
Different layers of the retina; optic nerve (ON), nerve fibre layer (NFL), ganglion cell layer (GCL), inner 297 
plexiform layer (IPL), inner nuclear layer (INL), outer plexiform layer (OPL), outer nuclear layer (ONL), outer 298 
segment layer (OS), retinal pigment epithelium (RPE) & choroid (Ch).  299 
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Structurally, these findings indicate a significant 11- and 7-fold increase in gene 300 
expression for TJP1 or often referred to as zonula occludens (ZO1), when RPE are grown 301 
in either a solo-culture, or in combination with MIO-M1 as a dual-culture or in a triple-302 
culture. This is also reflected within the barrier properties of the cultures, indicating a 303 
significantly strengthened barrier when MIO-M1 cells were grown on the basal side of 304 
the membrane. Previously published findings have associated Müller glial cell with 305 
tightened tight junctions and upregulated and polarized localization of specific blood-306 
brain-barrier transporters19, 22. However, expansion of these findings would require 307 
protein analysis to determine the downstream impact.  308 
Within DR and retinal disease, often researched is the alteration of key genes. 309 
Gerhardinger and colleagues report that in mice, 6 months post streptozotocin 310 
induction of diabetes, resulted in the alteration of 78 genes within Müller glial cells23. 311 
Over a third of these genes were reported to be associated with inflammation and 312 
inflammatory response including cytokines such as VEGF5, 23. These inflammatory 313 
cytokines can initiate a cascade of events within the retinal microenvironment and result 314 
in dysfunction of various cell types. The findings of this model indicate that within a 315 
triple-culture, expression of VEGF was significantly altered within HRMVEC; we 316 
hypothesise this is due to the presence of MIO-M1 cells.  PEDF expression is often 317 
demonstrated in literature to promote the health of the BRB24, 25; within this model we 318 
show a marked increase in PEDF gene expression. We hypothesise that the triple-culture 319 
system promotes the functionality of the BRB, not only structurally through the 320 
promotion of TJP1/ZO1, but also by an increase in the expression of beneficial growth 321 
factors such as PEDF and decreasing the expression of detrimental growth factors such 322 
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as VEGF. This data highlights the significance of using a multi-culture system within the 323 
assessment of disease mechanism, as a solo-culture would not elucidate the effect of 324 
the native environment due to the implications of additional cell types. Let alone this 325 
model does not represent all cell types present within the retina, it does provide species 326 
specificity and three cell type interactions, therefore improving on the current retinal 327 
models available and published. 328 
Often disputed in literature, is the use of cell lines in model design due to the 329 
presence of developmental abnormalities17, 26. The prolonged culture of both ARPE-19 330 
and MIO-M1 can result in abnormalities in characteristic features of the cell such as the 331 
loss of pigmentation in ARPE-19 and MIO-M1 exhibiting progenitor characteristics27. 332 
However, within our study design we have allowed for maturation and low passage 333 
numbers to ensure manipulation of culture conditions will result in minimal difference 334 
from parent tissue26. The superior use of an alternative cell source i.e. primary cell 335 
sources will yield a truer representation of the native tissue. However, it can also 336 
produce poor efficiency of the model in practice allowing for restricted use of repeats 337 
and minimise use in pharmacological testing. Additionally, models do not allow for the 338 
manipulation of culture environments to exacerbate a disease effect, for example; 339 
chronic exposure to high glucose and varying glycaemic levels during cell seeding and 340 
growth, to induce phenotypes seen in DR. Due to difficulties in sourcing human primary 341 
cells for the modelling of the retina, to date only a rodent in vitro model19 and no human 342 
multi-culture system have been published. We propose the compromise of two highly 343 
characterized and routinely used cell lines ARPE-1928-30 and MIO-M120, 27; and one 344 
primary sourced cell origin ACBRI-181 within this model, allowed for an in vitro multi-345 
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culture model to be utilized in place of either an in vitro mixed species model or an in 346 
vivo/in vitro animal model.  347 
In conclusion, our methodology provides evidence for a novel multi-cell in vitro 348 
culture model of the human retina, for the assessment of retinal biology and disease 349 
mechanisms. The versatility of the model allows the assessment of both singular cellular 350 
function within the retinal microenvironment in addition to a triple-cell assessment of 351 
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Supplementary Work 448 
Fluorescent immunocytochemical staining and imaging of cultures 449 
RPE were grown on 0.1% gelatin coated microscope cover slips and left to mature for 28 450 
days. Both MIO-M1 and HRMVEC were grown as described on Transwell® membrane. 451 
All culture formations (solo, dual and triple) followed the system set up as stated, they 452 
were then rinsed in PBS and fixed in ice-cold PBS containing 4% formaldehyde for 30 453 
minutes. Cultures were washed with wash buffer (1% BSA in PBS (Sigma Aldrich, UK)), 454 
then blocking and permeabilization were achieved by incubation with 5% BSA in 1xPBS 455 
with 0.3% Triton X-100 for 40 minutes prior to the addition of primary antibody 456 
(prepared in blocking buffer) which was incubated overnight at 4°C. The following 457 
conjugated primary antibodies were used: ZO-1 and AlexaFlour 488 (1:100, Thermo 458 
Fisher Scientific, UK), Von Willebrand factor and AlexaFlour 594 (1:1500, Novus Bio, UK) 459 
and Glutamine synthetase and AlexaFlour 488 (1:500, Novus Bio, UK). Post overnight 460 
incubation, cells were washed in wash buffer. This was followed by two washes in PBS 461 
and cultures were incubated with 1μg/ml 4’, 6’-diamino-2-phenylindole (DAPI; D9542, 462 
Sigma Aldrich, UK) for 5 minutes. All cultures were washed an additional two times in 463 
PBS and once in deionized H2O and mounted using PBS and 0.3% Tween-100 as 464 
mounting medium (Sigma Aldrich, UK). RPE were mounted straight to slides by inverting 465 
coverslips, MIO-M1 and HRMVEC grown on inserts were mounted between two glass 466 
coverslips with prior to imaging with a Zeiss microscope with Axiocam MR3 and image 467 




 Sup.Figure 1A-C. Immunocytochemical analysis of cells grown in triple-culture, A- ZO-1 expression in 470 
RPE after 28 day maturation marked with Alexa 488 (green), B- Von Willebrand factor expression in 471 
HRMVEC grown on the basal side of the membrane marked with Alexa 568 (red), C- Glutamine 472 
synthetase expression in MIO-M1 grown on the apical side of the membrane marked with Alexa 488 473 
(green). A-C all cells counterstained with nuclear stain DAPI (blue). Scale 50 µM. 474 




Sup.Figure 2. Representation of Hematoxylin stained cells used in the assessment of cell morphology 476 
including analysis of diameter (µM) by ImageJ software. A- RPE solo-culture, B- RPE dual-culture (+MIO-477 
M1), C- RPE dual-culture (+HRMVEC), D- RPE triple-culture, E- MIO-M1 solo-culture, F- MIO-M1 dual-478 
culture (+RPE), G- MIO-M1 dual-culture (+HRMVEC), H- MIO-M1 triple-culture, I- HRMVEC solo-culture, 479 
J- HRMVEC dual-culture (+RPE) & K- HRMVEC dual-culture (+MIO-M1).  480 
 481 
